Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models-Reference-Cited by-同舟云学术

Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models

Published:2019-02-26 Issue:2 Volume:14 Page:e0206309
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Owonikoko Taofeek K.^ORCID,Zhang Guojing,Lallani Shenila B.,Chen Zhengjia,Martinson Deborah E.,Khuri Fadlo R.,Lonial Sagar,Marcus Adam,Sun Shi-Yong

Funder

Novartis Pharmaceuticals Corporation

Foundation for the National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Cancer statistics, 2015;RL Siegel;CA Cancer J Clin,2015

2. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005;AY Chen;Cancer,2009

3. Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells;D Pasquali;J Mol Endocrinol,2008

4. Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways;Y Zou;Oncology reports,2009

5. Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue;M Li;J Am Coll Surg,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer;Biomedicines;2024-06-10

2. Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge;Andrology;2024-04-04

3. Somatostatin and Somatostatin Receptors in Tumour Biology;International Journal of Molecular Sciences;2023-12-28

4. Utilization of macrocyclic peptides to target protein-protein interactions in cancer;Frontiers in Oncology;2022-11-17

5. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice;Iranian Journal of Allergy, Asthma and Immunology;2022-06-21